- Home
- ASRV vs LEXX Comparison
ASRV vs LEXX Comparison
Compare ASRV & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASRV
- LEXX
- Stock Information
- Founded
- ASRV 1983
- LEXX 2004
- Country
- ASRV United States
- LEXX Canada
- Employees
- ASRV N/A
- LEXX N/A
- Industry
- ASRV Major Banks
- LEXX Biotechnology: Pharmaceutical Preparations
- Sector
- ASRV Finance
- LEXX Health Care
- Exchange
- ASRV Nasdaq
- LEXX Nasdaq
- Market Cap
- ASRV 45.1M
- LEXX 39.1M
- IPO Year
- ASRV N/A
- LEXX N/A
- Fundamental
- Price
- ASRV $2.57
- LEXX $1.45
- Analyst Decision
- ASRV
- LEXX Strong Buy
- Analyst Count
- ASRV 0
- LEXX 2
- Target Price
- ASRV N/A
- LEXX $9.50
- AVG Volume (30 Days)
- ASRV 10.0K
- LEXX 109.2K
- Earning Date
- ASRV 04-15-2025
- LEXX 04-08-2025
- Dividend Yield
- ASRV 4.54%
- LEXX N/A
- EPS Growth
- ASRV N/A
- LEXX N/A
- EPS
- ASRV 0.21
- LEXX N/A
- Revenue
- ASRV $53,139,000.00
- LEXX $496,923.00
- Revenue This Year
- ASRV N/A
- LEXX $30.72
- Revenue Next Year
- ASRV N/A
- LEXX $31.85
- P/E Ratio
- ASRV $12.52
- LEXX N/A
- Revenue Growth
- ASRV 18.14
- LEXX 77.63
- 52 Week Low
- ASRV $2.20
- LEXX $1.38
- 52 Week High
- ASRV $3.06
- LEXX $6.85
- Technical
- Relative Strength Index (RSI)
- ASRV 40.99
- LEXX 33.85
- Support Level
- ASRV $2.54
- LEXX $1.38
- Resistance Level
- ASRV $2.74
- LEXX $1.72
- Average True Range (ATR)
- ASRV 0.14
- LEXX 0.12
- MACD
- ASRV -0.01
- LEXX -0.01
- Stochastic Oscillator
- ASRV 9.68
- LEXX 12.85
About ASRV AmeriServ Financial Inc.
AmeriServ Financial Inc is a bank holding company. The company and its subsidiaries derive substantially all of their income from banking, bank-related services, and trust-related services. Its operating segment includes community banking; wealth management and investment/parent. The company generates maximum revenue from the community banking segment. The community banking segment includes both retail and commercial banking activities. Retail banking includes the deposit-gathering branch franchise and lending to both individuals and small businesses. Lending activities include residential mortgage loans, direct consumer loans and small business commercial loans. Commercial banking to businesses includes commercial loans, business services, and CRE loans.
About LEXX Lexaria Bioscience Corp.
Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.